Introduction
Intracerebroventricularly (i.c.v.) administered thyrotropin releasing hormone {TRH) increases blood pressure and heart rate in various animal speciesr 1 -3 1. Also, when given intravenously (i.v.) to man for testing hypophyseal function, TRH increases blood pressurer 4 J. We have recently shown, in the rat, that TRH injected into the fourth cerebral ventricle induced a more rapid hypertensive effect than when injected into the lateral ventricle[sJ. Moreover, hypertension persisted when TRH was injected into the fourth ventricle if its access to the rest of the cerebral cavities was hindered by blockade of the cerebral aqueduct. Therefore, the brain stem appeared to be the main site for the hypertensive action of TRH.
The present study provides further evidence of an extrahypothalamic site for the cardiovascular action of TRH by comparing effects of its administration i.c.v. and locally in the region of the locus coeruleus.
Methods
Male Wister rats (250-370 g) were anaesthetized with urethane (1.5 g kg-1 intraperitoneally) and the tracheawas cannulated for recording of spontaneous ventilation. The left femoral artery was cannulated for recording of blood pressure. Expiratory air flow was recorded by means of a hot wire fiow meter p1aced at the opening of the tracheal tube. Colonic temperature was maintained at 37 ± 0·3°C by means of a heating pad controlled by a thermistor probe.
The rats were held in a stereotaxic instrument for i.c.v. or intracerebral (i.c.) injections. The technique for cannulation of the lateral cerebral ventricle, and details of the computerized recording system, have been described previouslyr 6 • 71 • For i.c. injections, a stainless steel guide cannula was inserted bilaterally at the following coordinates in reference to the bregma: AP = -6.2, L = 1.0, V= 2.0 mm. To reach the region of locus coeruleus, a 30G stainless steel tubing was inserted via the guide cannula. The coordinates . were defined according to the atlas of Pellegrino et al. rsJ In the vertical plane, depths of 6.0 or 7.0 mm from the skull surface proved to correspond to the Ievel of the locus coeruleus. Details of post-mortem verification of injection sites are shown in Fig. 1 .
The injections were given within 15 s in volumes of 1 111 (i.c.) or 10 111 (i.c.v.). At the end of the experiment, the tip of the cannula was marked with methy1ene b1ue for verification of the injection site. Each brain was then removed and stored in formalin and cut after 48 h in seria1 slices (50 Jl.ID) for microscopic examination.
TRH hydroch1oride (Sigma Chemical Co.) was dissolved in saline (0.9% NaCI wfv).
Two-way analysis of variance for i-epeated measures was used for statistical assessment. The difference between two groups was denoted as significant at the level of P ( 0·05 {Tukey's test). Calculations were carried out by a V AX-8600 computer using SAS statistical software. The results are expressed as means ±SE.
Results

ADMINISTRATION OF TRH IN THE REGION OF THE LOCUS COERULEUS
TRH, 10 pmol kg-1 i.c., increased mean arterial pressure (MAP) by 24 mm Hg within 1 min, whereas the effect of 1 pmol kg-1 was not significantly different from the saline control group [ Fig. 2(a) ]. Compared with the saline control, neither of the treatment doses of TRH significantly affected heart rate [ Fig. 2(b) ] or ventilation rate [ Fig. 2(c) ].
Ventilation tidal volume was changed less than 10% during the 10-min follow-up after injection.
These changes were not statistically significant. Baseline values for tidal volumes (in ml) were as follows: 1 pmol kg-1 , 1 ± 0·1 (N = 8); 10 pmol kg-1 1·2 ± 0·2 (N = 7); and saline, 0·93 ± 0·1 (N = 6).
ADMINISTRATION OF TRH INTO THE LATERAL VENTRICLE
TRH, 100 pmol kg-1 i.c.v., increased MAP maximally by 14 mmHg within 5 min of the injection [ Fig. 3(a) ]. Doses of 1 or 10 pmol kg-1 failed to alter MAP significantly.
Doses of 10 and 100 pmol kg-1 of TRH i.c.v. increased heart rate to the same amount. The peak effects (about 25 min-1 for both treatments) were reached within 5 min [ Fig. 3(b ) ]. The effect of 1 pmol kg-1 did not significantly differ from that ofthe salinetreated group.
TRH 100 pmol kg-1 i.c.v. increased ventilationrate maximally by 15 breaths min-1 within 3 min [ Fig.  3(c) ]. The two lower doses of TRH caused no The differences between the groups were not significant. 
Discussion
We have previously suggested that at least a part of the hypertensive effect of TRH is mediated via the brain stemlsl. Two pieces of evidence are avai1able. Firstly, TRH induced a more rapid hypertensive response when injected into the fourth ventricle compared with injection into the lateral ventricle. Secondly, blocking the cerebral aqueduct did not attenuate the hypertensive action of TRH injected into the fourth ventricle, but abolished that after injection into the lateral vetricle, indicating that brain areas rostral to the block were not essential for the pressor effects of TRH.
The present findings show that an almost instantaneous hypertensive response (1 min) is obtained when TRH is injected into the region of the locus coeruleus compared to the much slower pressor effect after injection into the lateral ventricle and the intermediate response (3 min) after fourth ventricle administration seen in a previous studyl 51 . However, the effects of TRH were equal for both of these cerebroventricular routes of administration probably due to extensive mixing of the cerebraspinal fluidl
.
The present results also indicate that TRH doses more than ten times larger were needed i.c.v. than in the area of locus coeruleus to obtain similar increases in arterial pressure.
Diz and Jacobowitzl 101 . reported slight increases of blood pressure after injection of TRH into the preoptic suprachiasmatic and medial preoptic nuclei at the dose of 1.4 pmol. However, the latent period between injection and peak effect was four times Ionger than in the present study, suggesting that the injection site was some distance from the locus of action. Likewise, the considerable latency of effect (10 min), despite a larger dose (nanomoles) injected into the medial preoptic nucleusl 111 suggests that this site is not involved in the hypertensive effect of TRH.
Administration of TRH into the region of the locus coeruleus failed to elicit any clear-cut tachycardia or stimulation of ventilation. Two previous studies also suggested that the site of TRH-induced tachycardia is not identical to that mediating hypertensionls. 12 1. The exact location of centres mediating the hypertensive action of TRH in the rostral brain stem remains to be defined. lt is likely that more than one nucleus is involved. That the sites of action reside in the immediate vicinity of the locus coerulus is suggested by the small dose of TRH required to elicit a clear increase in blood pressure, and the short interval between injection and the pressor response. In addition to the locus coeruleusl 131 , the nucleus parabrachialis may also be involved, because of its known regulatory rolel 141 • Furthermore, both of the aforementioned sites have a high content of immunoreactive TRHl 15 1.
The observations that most TRH is found outside the hypothalmus, that its binding sites are widely distributed throughout the central nervous system, and that it is present in nerve terminals, suggest a role for TRH as a neurotransmitterl 161 . The present findings, tagether with the biochemical and neuroanatomical data, suggest that TRH may have a physiological role in the regulation of the cardiovascular system.
